Genome editing reveals a role for OCT4 in human embryogenesis

Area of Science:

• Developmental Biology
• Genetics
• Stem Cell Biology

Background:

• The initial cell fate decisions in human embryogenesis are critical but poorly understood.
• The transcription factor OCT4 plays a key role in pluripotency and early development.

Purpose of the Study:

• To investigate the function of OCT4 during human embryogenesis using CRISPR-Cas9 genome editing.
• To refine methods for efficient gene targeting in human zygotes.

Main Methods:

• CRISPR-Cas9 genome editing was used to target the POU5F1 gene (encoding OCT4) in diploid human zygotes.
• An efficient OCT4-targeting guide RNA was identified using human embryonic stem cells and mouse zygote microinjection.
• Transcriptomics analysis was performed on POU5F1-null human cells.

Main Results:

• Targeting POU5F1 in human zygotes compromised blastocyst development.
• POU5F1-null human cells showed downregulated expression of trophectoderm (e.g., CDX2) and epiblast (e.g., NANOG) genes.
• Pou5f1-null mouse embryos showed compromised, but not abolished, blastocyst development and gene expression.

Conclusions:

• CRISPR-Cas9 genome editing is effective for studying gene function in human development.
• OCT4 is essential for proper blastocyst development and cell fate decisions in human embryos.
• OCT4's role in human development differs from its role in mouse development.